Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective

Biliary tract cancer (BTC) is a group of rare and aggressive malignancies with a dismal prognosis. There is currently a significant lack in effective treatment options for BTC, with gemcitabine-cisplatin remaining the first-line standard of care treatment for over a decade. A wave of investigational...

Descripción completa

Detalles Bibliográficos

Autores principales:	Vincent C. Tam, Ravi Ramjeesingh, Ronald Burkes, Eric M. Yoshida, Sarah Doucette, Howard J. Lim
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-09-01
Colección:	Current Oncology
Materias:	biliary tract cancer rare disease chemotherapy immunotherapy targeted therapy drug access
Acceso en línea:	https://www.mdpi.com/1718-7729/29/10/555
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!